vs
Side-by-side financial comparison of ACME UNITED CORP (ACU) and Evolus, Inc. (EOLS). Click either name above to swap in a different company.
Evolus, Inc. is the larger business by last-quarter revenue ($73.1M vs $52.3M, roughly 1.4× ACME UNITED CORP). ACME UNITED CORP runs the higher net margin — 1.9% vs -14.6%, a 16.5% gap on every dollar of revenue. On growth, ACME UNITED CORP posted the faster year-over-year revenue change (13.8% vs 6.7%). Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (4.6% CAGR vs -2.9%).
Acme United Corporation is a supplier of cutting, measuring and safety products for the school, home, office, hardware and industrial markets. The company was organized as a partnership in 1867 and incorporated in 1873 under the laws of the State of Connecticut. It is publicly traded on the NYSE American with symbol ACU.
Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.
ACU vs EOLS — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $52.3M | $73.1M |
| Net Profit | $985.0K | $-10.7M |
| Gross Margin | 39.7% | 66.9% |
| Operating Margin | 3.3% | 23.8% |
| Net Margin | 1.9% | -14.6% |
| Revenue YoY | 13.8% | 6.7% |
| Net Profit YoY | -40.4% | — |
| EPS (diluted) | $0.24 | $-0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $52.3M | $73.1M | ||
| Q4 25 | $47.5M | $90.3M | ||
| Q3 25 | $49.1M | $69.0M | ||
| Q2 25 | $54.0M | $69.4M | ||
| Q1 25 | $46.0M | $68.5M | ||
| Q4 24 | $45.9M | $78.9M | ||
| Q3 24 | $48.2M | $61.1M | ||
| Q2 24 | $55.4M | $66.9M |
| Q1 26 | $985.0K | $-10.7M | ||
| Q4 25 | $1.9M | $130.0K | ||
| Q3 25 | $1.9M | $-15.7M | ||
| Q2 25 | $4.8M | $-17.1M | ||
| Q1 25 | $1.7M | $-18.9M | ||
| Q4 24 | $1.7M | $-6.8M | ||
| Q3 24 | $2.2M | $-19.2M | ||
| Q2 24 | $4.5M | $-11.3M |
| Q1 26 | 39.7% | 66.9% | ||
| Q4 25 | 38.2% | 65.7% | ||
| Q3 25 | 39.1% | 66.5% | ||
| Q2 25 | 41.0% | 65.3% | ||
| Q1 25 | 39.0% | 68.1% | ||
| Q4 24 | 38.7% | 66.7% | ||
| Q3 24 | 38.5% | 68.9% | ||
| Q2 24 | 40.8% | 70.3% |
| Q1 26 | 3.3% | 23.8% | ||
| Q4 25 | 6.1% | 4.7% | ||
| Q3 25 | 6.1% | -16.7% | ||
| Q2 25 | 11.8% | -14.7% | ||
| Q1 25 | 5.3% | -22.1% | ||
| Q4 24 | 5.0% | -2.9% | ||
| Q3 24 | 6.1% | -25.3% | ||
| Q2 24 | 11.5% | -11.5% |
| Q1 26 | 1.9% | -14.6% | ||
| Q4 25 | 3.9% | 0.1% | ||
| Q3 25 | 3.9% | -22.8% | ||
| Q2 25 | 8.8% | -24.7% | ||
| Q1 25 | 3.6% | -27.6% | ||
| Q4 24 | 3.7% | -8.6% | ||
| Q3 24 | 4.6% | -31.4% | ||
| Q2 24 | 8.0% | -17.0% |
| Q1 26 | $0.24 | $-0.16 | ||
| Q4 25 | $0.46 | $0.01 | ||
| Q3 25 | $0.46 | $-0.24 | ||
| Q2 25 | $1.16 | $-0.27 | ||
| Q1 25 | $0.41 | $-0.30 | ||
| Q4 24 | $0.43 | $-0.11 | ||
| Q3 24 | $0.54 | $-0.30 | ||
| Q2 24 | $1.09 | $-0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.2M | $49.8M |
| Total DebtLower is stronger | $33.0M | $156.4M |
| Stockholders' EquityBook value | $116.7M | — |
| Total Assets | $195.2M | $220.6M |
| Debt / EquityLower = less leverage | 0.28× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $4.2M | $49.8M | ||
| Q4 25 | $3.6M | $53.8M | ||
| Q3 25 | $5.1M | $43.5M | ||
| Q2 25 | $3.6M | $61.7M | ||
| Q1 25 | $3.4M | $67.9M | ||
| Q4 24 | $6.4M | $87.0M | ||
| Q3 24 | $5.7M | $85.0M | ||
| Q2 24 | $3.8M | $93.7M |
| Q1 26 | $33.0M | $156.4M | ||
| Q4 25 | — | $146.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $121.8M | ||
| Q4 24 | — | $121.5M | ||
| Q3 24 | — | $121.2M | ||
| Q2 24 | — | $120.9M |
| Q1 26 | $116.7M | — | ||
| Q4 25 | $117.6M | $-23.1M | ||
| Q3 25 | $115.8M | $-28.8M | ||
| Q2 25 | $113.7M | $-18.7M | ||
| Q1 25 | $108.3M | $-6.6M | ||
| Q4 24 | $107.0M | $5.5M | ||
| Q3 24 | $106.3M | $5.9M | ||
| Q2 24 | $104.0M | $19.3M |
| Q1 26 | $195.2M | $220.6M | ||
| Q4 25 | $171.0M | $225.9M | ||
| Q3 25 | $173.0M | $219.0M | ||
| Q2 25 | $170.9M | $228.8M | ||
| Q1 25 | $163.0M | $213.4M | ||
| Q4 24 | $162.2M | $232.6M | ||
| Q3 24 | $165.5M | $229.6M | ||
| Q2 24 | $173.5M | $233.8M |
| Q1 26 | 0.28× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 22.00× | ||
| Q3 24 | — | 20.58× | ||
| Q2 24 | — | 6.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACU
Segment breakdown not available.
EOLS
| Product revenue, net | $72.7M | 99% |
| Service revenue | $390.0K | 1% |
